ArticleFrontiers in immunology2025

Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients.

Marina Mané-Damas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.